HCV Polyprotein 1406-1415 (HLA-A*02:01)
( KLVALGINAV )
KLVALGINAV is a linear peptidic epitope studied as part of Genome polyprotein from Hepatitis C virus. Single peptide (KLVALGINAV) for stimulation of human HCV NS3 (1406-1415)-specific CD8+ T cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*02:01 allele.
| Sequence: | KLVALGINAV | |
| Gene: | N/A | |
| Delivery: | 3 weeks | |
| C-Terminus: | OH | |
| N-Terminus: | H | |
| Amount: | 1 mg | |
| Counter Ion: | TFA | |
| Protein: | Genome polyprotein | |
| Species: | HCV | |
| Allele: | HLA-A*02:01 | |
| Application : | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
| Indication : | Hepatitis | |
| Purity : | 95% HPLC-MS |
Protocols and Tips
Data sheets
Safety data sheet poly peptides:
Special references for this product will come soon.
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
€60.40*
Delivery time 2-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Product number:
EP07916_1